occult cancer

(1) Occult primary malignancy
(2) Clinically inapparent malignancy, pathologist’s tumour A lesion defined as malignant by histologic criteria, which is an incidental discovery that occurs either when a patient is being evaluated for other reasons, or at the time of autopsy, as may occur in cancer of the prostate and thyroid

occult cancer

2. Clinically inapparent malignancy, pathologist's tumor A lesion defined as malignant by histologic criteria, which is an incidental discovery that occurs either when a Pt is being evaluted for other reasons, or at the time of autopsy, as has been well-documented in CA of the prostate and thyroid.
References in periodicals archive ?
Before we can adopt prostate-sparing cystectomies as a routine option for muscle invasive bladder cancer, the potential risk of residual occult cancer in the prostate must considered.
It was noticed that the cancer (karkindma; carcinoma in Latin) could be preceded by an occult cancer (karkinos kruptos).
Washington, Jan 13 (ANI): Scientists have found that the use of preoperative breast MRI detects otherwise occult cancer with a relatively high degree of accuracy when applied to a diverse population of patients newly diagnosed with breast cancer.
In a retrospective study in 159 women with at least one biopsy-proven cancer, follow-up breast-specific gamma imaging (BSGI) identified clinically and mammographically occult cancer in 14 of 45 lesions.
Phosphopeptide biomarkers for early breast cancer detection in women with mammographically occult cancer
People think that dietary intake of these nutrients reflects a lifelong healthy eating habit, and in those cases, these nutrients may be protective, but they could have an opposite effect if they are used in a person with an occult cancer," Dr.
Women were more likely to have occult cancer at RRSO if they had BRCA 1/2 mutations (odds ratio, 11.
In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: The Mayo Clinic in Florida experience.
The smallest invasive cancer and DCIS detected were both 1 mm, and BSGI helped detect occult cancer not visualized at mammography or ultrasonography in six patients.
The first product offered through the Irvine laboratory is the company's recently launched ConfirmMDx[TM] for Prostate Cancer test, which provides urologists with a DNA-based epigenetic assay to help distinguish patients who have a true-negative prostate biopsy from those who may have occult cancer.
These included cases in 108 women with intact ovaries who were diagnosed clinically, 46 cases of occult cancer diagnosed at oophorectomy, and 32 cases of peritoneal cancer that developed after oophorectomy.
In a recent review of 371 patients who underwent surgery for high-grade dysplasia, the incidence of occult cancer was 42%.